Public SEC Form D records
Biotech Series B Form D filings - June 2026
This page lists the 9 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series B stage in June 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 9
- Issuers
- 9
- Combined disclosed
- $224.8M
Directory links
Filing records
9 crawlable filing links in this facet.
- Cresilon, Inc.June 26, 2026 / Reg D 506(c) / NY$29.0M
- Rapalogix Health, Inc.June 26, 2026 / Reg D 506(b) / CA$25.0M
- Rejuvenate Bio IncJune 18, 2026 / Reg D 506(b) / CA$27.0M
- Eos SENOLYTIX, Inc.June 12, 2026 / Reg D 506(b) / TX$25.0M
- Anodyne Nanotech, Inc.June 11, 2026 / Reg D 506(b) / MA$17.3M
- Antlia Bioscience, Inc.June 5, 2026 / Reg D 506(b) / CA$20.0M
- Bond Biosciences, Inc.June 4, 2026 / Reg D 506(b) / MO$15.0M
- Senti Biosciences Holdings, Inc.June 4, 2026 / Reg D 506(b) / CA$40.0M
- Nia Therapeutics, Inc.June 3, 2026 / Reg D 506(b) / MA$26.5M